S7-4 Steady-State Pharmacokinetics of Lamivudine in Plasma following Administration of Lamivudine at 300 mg Once Daily and 150 mg Twice Daily in HIV-infected patients(S7 CJK(China-Japan-Korea: CJK) alliance for Pharmaceutical health care and Sciences 2009
スポンサーリンク
概要
- 論文の詳細を見る
- 日本医療薬学会の論文
- 2009-09-15
著者
-
Lu Wang
Department Of Infection Peking Union Medical College Hospital Chinese Academy Of Medical Sciences-pe
-
Qiang Fu
Department Of Pharmacy Peking Union Medical College Hospital Chinese Academy Of Medical Sciences-pek
-
Min Ye
Department Of Pharmacy Peking Union Medical College Hospital Chinese Academy Of Medical Sciences-pek
-
Zhu Zhu
Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences-P
-
Taisheng Li
Department of Infection, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences-
-
Peng Li
Department of Pharmacy, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences-P
-
Taisheng Li
Department Of Infection Peking Union Medical College Hospital Chinese Academy Of Medical Sciences-pe
-
Peng Li
Department Of Pharmacy Peking Union Medical College Hospital Chinese Academy Of Medical Sciences-pek
-
Peng Li
Department Of Chemistry Yunnan University
関連論文
- Source/Drain Engineering for In0.7Ga0.3As N-Channel Metal--Oxide--Semiconductor Field-Effect Transistors: Raised Source/Drain with In situ Doping for Series Resistance Reduction
- S7-4 Steady-State Pharmacokinetics of Lamivudine in Plasma following Administration of Lamivudine at 300 mg Once Daily and 150 mg Twice Daily in HIV-infected patients(S7 CJK(China-Japan-Korea: CJK) alliance for Pharmaceutical health care and Sciences 2009
- Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis
- 20-P2-CJK01 Genetic polymorphism and the activity analysis of dihydropyrimidine dehydrogenase in 130 patients with gestational trophoblastic disease
- Construction and Performance Characteristics of New Fentanyl-Selective Plastic Membrane Electrode
- B-cell epitope KT-12 of enterohemorrhagic Escherichia coli O157:H7 : a novel peptide vaccine candidate